{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:30:02Z","timestamp":1789777802022,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.soc.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T09:12:19Z","timestamp":1729761139000},"page":"21-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pathophysiology of Anal Cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Taja","family":"Lozar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evie","family":"Carchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2024.07.003_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40291-023-00692-9","article-title":"Unraveling emerging anal cancer clinical biomarkers from current immuno-oncogenomics advances","volume":"28","author":"Iseas","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.soc.2024.07.003_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.suc.2020.02.007","article-title":"Anal Cancer","volume":"100","author":"Young","year":"2020","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.soc.2024.07.003_bib4","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciac044","article-title":"Anal cancer screening and prevention: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infection guidelines","volume":"74","author":"Barroso","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A\u00a0meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib6","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4161\/hv.29137","article-title":"HPV vaccination in boys and men","volume":"10","author":"Stanley","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.soc.2024.07.003_bib7","doi-asserted-by":"crossref","first-page":"e181999","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus-associated cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.soc.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/path.4858","article-title":"Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma","volume":"241","author":"Herfs","year":"2017","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.soc.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/v9040085","article-title":"Deciphering the multifactorial susceptibility of mucosal junction cells to HPV infection and related carcinogenesis","volume":"9","author":"Herfs","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.soc.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.soc.2024.07.003_bib11","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/QAD.0b013e3283633111","article-title":"Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men","volume":"27","author":"Tong","year":"2013","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.soc.2024.07.003_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00105-020-04562-x","article-title":"Anal dysplasia and anal cancer. English version","volume":"71","author":"Wieland","year":"2020","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb"},{"key":"10.1016\/j.soc.2024.07.003_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/DCR.0000000000001384","article-title":"Risk of invasive anal cancer in HIV-infected patients with high-grade anal dysplasia: a population-based cohort study","volume":"62","author":"Arens","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.soc.2024.07.003_bib15","first-page":"185","article-title":"Risk of anal cancer following benign anal disease and anal cancer precursor lesions: a danish nationwide cohort study","volume":"29","author":"Faber","year":"2020","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2024.07.003_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.soc.2024.07.003_bib19","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.77.5.2832-2842.2003","article-title":"Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle","volume":"77","author":"Genther","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.soc.2024.07.003_bib20","first-page":"324","article-title":"Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib21","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1038\/ncomms7537","article-title":"The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NF\u03baB activation","volume":"6","author":"Tummers","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.soc.2024.07.003_bib22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/carcin\/bgn145","article-title":"Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes","volume":"29","author":"Caberg","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.soc.2024.07.003_bib23","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.22089","article-title":"E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain","volume":"119","author":"Ashrafi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2024.07.003_bib25","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","article-title":"Impact of the HIV epidemic on the incidence rates of anal cancer in the United States","volume":"104","author":"Shiels","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2024.07.003_bib26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America","volume":"54","author":"Silverberg","year":"2012","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"10.1016\/j.soc.2024.07.003_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/ciw764","article-title":"HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers","volume":"64","author":"Shiels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soc.2024.07.003_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal cancer risk among people with HIV infection in the United States","volume":"36","author":"Col\u00f3n-L\u00f3pez","year":"2018","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/dji073","article-title":"Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women","volume":"97","author":"Strickler","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2024.07.003_bib31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00042560-199804010-00004","article-title":"Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men","volume":"17","author":"Palefsky","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirology Off Publ Int Retrovirology Assoc"},{"key":"10.1016\/j.soc.2024.07.003_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/QAD.0000000000000537","article-title":"HAART slows progression to anal cancer in HIV-infected MSM","volume":"29","author":"Duncan","year":"2015","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.soc.2024.07.003_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/QAI.0000000000000675","article-title":"Brief report: anal cancer in the HIV-positive population: slowly declining incidence after a decade of cART","volume":"69","author":"Richel","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.soc.2024.07.003_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CEJ.0000000000000842","article-title":"Global trends in anal cancer incidence and mortality","volume":"33","author":"Mignozzi","year":"2024","journal-title":"Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP"},{"key":"10.1016\/j.soc.2024.07.003_bib36","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.29670","article-title":"Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration","volume":"137","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s003840050145","article-title":"Papillomavirus and anal carcinoma","volume":"13","author":"Poletti","year":"1998","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib38","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib39","first-page":"1","article-title":"Prevalence of HPV in Adults Aged 18-69: United States, 2011-2014","author":"McQuillan","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.soc.2024.07.003_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17474124.2020.1775583","article-title":"A\u00a02020 update of anal cancer: the increasing problem in women and expanding treatment landscape","volume":"14","author":"Lum","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.soc.2024.07.003_bib41","doi-asserted-by":"crossref","first-page":"e0259245","DOI":"10.1371\/journal.pone.0259245","article-title":"Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice","volume":"16","author":"Walcheck","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.soc.2024.07.003_bib42","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/bjc.2015.89","article-title":"Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years","volume":"112","author":"Coffey","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/91.8.708","article-title":"Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism?","volume":"91","author":"Frisch","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2024.07.003_bib44","doi-asserted-by":"crossref","first-page":"e0205105","DOI":"10.1371\/journal.pone.0205105","article-title":"Anal cancer in high-income countries: Increasing burden of disease","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.soc.2024.07.003_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib46","first-page":"837","article-title":"Risk factors for anal cancer: results of a population-based case--control study","volume":"14","author":"Tseng","year":"2003","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.soc.2024.07.003_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pvr.2017.10.004","article-title":"Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions","volume":"4","author":"McCloskey","year":"2017","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.soc.2024.07.003_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrgentox.2004.02.014","article-title":"Smoking-related DNA adducts in anal epithelium","volume":"560","author":"Phillips","year":"2004","journal-title":"Mutat Res"},{"key":"10.1016\/j.soc.2024.07.003_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ijc.25080","article-title":"Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978\u20132005","volume":"127","author":"Sunesen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0142(19860801)58:3<611::AID-CNCR2820580303>3.0.CO;2-M","article-title":"Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases","volume":"58","author":"Penn","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0140-6736(94)92636-0","article-title":"High incidence of anal cancer among AIDS patients. The AIDS\/Cancer Working Group","volume":"343","author":"Melbye","year":"1994","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.soc.2024.07.003_bib53","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection","volume":"27","author":"Powles","year":"2009","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.olq.0000162366.60245.02","article-title":"Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy","volume":"32","author":"Diamond","year":"2005","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib55","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283023f78","article-title":"Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy","volume":"22","author":"Piketty","year":"2008","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.soc.2024.07.003_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.soc.2024.07.003_bib57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.soc.2024.07.003_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1054\/bjoc.2000.1153","article-title":"Anal carcinoma in inflammatory bowel disease","volume":"83","author":"Frisch","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bjc.1998.719","article-title":"Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma","volume":"78","author":"Frisch","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib60","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2024.07.003_bib61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/bjs.1800810313","article-title":"Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients","volume":"81","author":"Ogunbiyi","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2024.07.003_bib62","first-page":"366","article-title":"Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression","volume":"17","author":"Roka","year":"2004","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"key":"10.1016\/j.soc.2024.07.003_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00384-009-0778-z","article-title":"Squamous cell carcinoma of the anus in a patient with perianal Crohn\u2019s disease","volume":"25","author":"Kang","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.soc.2024.07.003_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1445-2197.1991.tb00131.x","article-title":"Crohn\u2019s disease and anal carcinoma: an association? A case report and review of the literature","volume":"61","author":"Lumley","year":"1991","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.soc.2024.07.003_bib65","first-page":"1453","article-title":"Risk of anorectal cancer in patients with Crohn\u2019s disease and perianal fistula: a nationwide Danish cohort study","volume":"25","author":"El-Hussuna","year":"2023","journal-title":"Colorectal Dis Off J Assoc Coloproctology G B Irel"},{"key":"10.1016\/j.soc.2024.07.003_bib66","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/BF02237388","article-title":"Carcinoma arising in anorectal fistulas of Crohn\u2019s disease","volume":"41","author":"Ky","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.soc.2024.07.003_bib67","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","article-title":"Anal neoplasia in inflammatory bowel disease: classification proposal, epidemiology, carcinogenesis, and risk management perspectives","volume":"11","author":"Wisniewski","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.soc.2024.07.003_bib68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ecco-jcc\/jjaa118","article-title":"The incidence and disease course of perianal Crohn\u2019s Disease: A Danish Nationwide Cohort Study, 1997-2015","volume":"15","author":"Wewer","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.soc.2024.07.003_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4251\/wjgo.v2.i7.307","article-title":"Mucinous carcinoma in Crohn\u2019s disease originating in a fistulous tract","volume":"2","author":"Freeman","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib70","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/17474124.2018.1500175","article-title":"Fistula-associated anal carcinoma in Crohn\u2019s disease","volume":"12","author":"Yamamoto","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.soc.2024.07.003_bib71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MEG.0b013e32836371a2","article-title":"Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn\u2019s disease","volume":"26","author":"Scharl","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.soc.2024.07.003_bib72","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/02841860701348670","article-title":"Late adverse effects of radiation therapy for rectal cancer \u2013 a systematic overview","volume":"46","author":"Birgisson","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib73","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3748\/wjg.v17.i25.2987","article-title":"Squamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexuals","volume":"17","author":"Gervaz","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.soc.2024.07.003_bib74","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bjs.5376","article-title":"Molecular biology of squamous cell carcinoma of the anus","volume":"93","author":"Gervaz","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2024.07.003_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<378::AID-PATH697>3.0.CO;2-H","article-title":"Properties of HPV-positive and HPV-negative anal carcinomas","volume":"180","author":"Williams","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.soc.2024.07.003_bib76","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.07.003_bib77","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/annonc\/mdw152","article-title":"Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes","volume":"27","author":"Chung","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2024.07.003_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/bjc.2016.398","article-title":"Biomarkers in anal cancer: from biological understanding to stratified treatment","volume":"116","author":"Jones","year":"2017","journal-title":"Br J Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:17:14Z","timestamp":1755011834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1055320724000437"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.07.003","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of Anal Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}